Bioengineering

A novel approach to analyzing yew tree genes has revealed key enzymes used to make Taxol, a chemotherapy drug that’s long been difficult and costly to produce.

Stanford researchers have developed a faster, more precise way to model and print vascular systems, solving a critical challenge in fabricating transplantable organs from patients’ own cells.

Stanford biochemist Lingyin Li’s lab is studying a tumor-fighting “miracle molecule” that could one day inform therapies for cancer, as well as autoimmune, neurodegenerative, and age-related diseases.

Drawing inspiration from our gut protection mechanisms, Stanford researchers have engineered a new type of sensor to monitor substances over long stretches – measuring reactions for up to a week after being implanted in living rats.

Researchers have discovered a small molecule that restores stressed mitochondria in human cells – damage tied to diseases including Parkinson’s, diabetes, and cancer. The work, now patented, could lead to the development of new treatments.

Stanford researchers have developed a technology that delivers RNA to damaged neurons and stimulates regrowth – paving the way for potential treatments targeting neurodegenerative diseases like ALS and spinal muscular atrophy.

Stanford bioengineer Stanley Qi is developing advanced gene-editing tools to treat life-threatening diseases and slow the onset of neurological aging.

Stanford and SLAC researchers have identified surprisingly intricate RNA-only complexes – offering inspiration for biomedical and biotechnological design.

A technique to see DNA as it moves in living cells could offer novel fundamental insights into biology.

Stanford bioengineer Mark Skylar-Scott is on a “science fiction” quest to 3D print human hearts and other organs on demand, using cells from a patient’s own body.